{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:12:50Z","timestamp":1782400370263,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Program of Education Department of Anhui Province","award":["2022AH052318"],"award-info":[{"award-number":["2022AH052318"]}]},{"DOI":"10.13039\/501100017668","name":"Key Research and Development Program of Anhui Province","doi-asserted-by":"crossref","award":["2022AH040163"],"award-info":[{"award-number":["2022AH040163"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Research Program of Anhui Province","award":["AHWJ2023A20079"],"award-info":[{"award-number":["AHWJ2023A20079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26955-5","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:56:19Z","timestamp":1764701779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing and validating a new metabolic marker-driven prognosis signature for cutaneous melanoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"26955_CR1","first-page":"1396","volume":"9","author":"G Che","year":"2019","unstructured":"Che, G. et al. Trends in incidence and survival in patients with melanoma, 1974\u20132013. Am. J. Cancer Res. 9, 1396\u20131414 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"26955_CR2","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. & Cancer statistics.  CA Cancer J. Clin. 71, 7\u201333. (2021).","DOI":"10.3322\/caac.21654"},{"key":"26955_CR3","first-page":"5091","volume":"16","author":"Z Xu","year":"2018","unstructured":"Xu, Z. et al. Spindle cell melanoma: incidence and survival, 1973\u20132017. Oncol. Lett. 16, 5091\u20135099 (2018).","journal-title":"Oncol. Lett."},{"key":"26955_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 158, 495 (2022).","journal-title":"JAMA Dermatol."},{"key":"26955_CR5","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli, M., Tropea, S., Rossi, C. R. & Alaibac, M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. Vivo 28, 1005\u20131011 (2014).","journal-title":"Vivo"},{"key":"26955_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0959-8049(98)00003-3","volume":"34","author":"RM MacKie","year":"1998","unstructured":"MacKie, R. M. Incidence, risk factors and prevention of melanoma. Eur. J. Cancer. 34, 3\u20136 (1998).","journal-title":"Eur. J. Cancer"},{"key":"26955_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"W Guo","year":"2021","unstructured":"Guo, W., Wang, H. & Li, C. Signal pathways of melanoma and targeted therapy. Sig Transduct. Target. Ther. 6, 424 (2021).","journal-title":"Sig Transduct. Target. Ther."},{"key":"26955_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaad.2004.04.045","volume":"51","author":"H Tsao","year":"2004","unstructured":"Tsao, H. & Niendorf, K. Genetic testing in hereditary melanoma. J. Am. Acad. Dermatol. 51, 803\u2013808 (2004).","journal-title":"J. Am. Acad. Dermatol."},{"key":"26955_CR9","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/1476-069X-11-S1-S12","volume":"11","author":"K Volkovova","year":"2012","unstructured":"Volkovova, K., Bilanicova, D., Bartonova, A., Leta\u0161iov\u00e1, S. & Dusinska, M. Associations between environmental factors and incidence of cutaneous melanoma. Rev. Environ. Health. 11, S12 (2012).","journal-title":"Rev. Environ. Health"},{"key":"26955_CR10","first-page":"943","volume":"59","author":"DE Br\u0103ni\u0219teanu","year":"2023","unstructured":"Br\u0103niteanu, D. E. et al. Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Med. (Mex). 59, 943 (2023).","journal-title":"Med. (Mex)"},{"key":"26955_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-0716-3008-2_6","volume":"2634","author":"K Kumar","year":"2023","unstructured":"Kumar, K. et al. Integrating Multi-Omics data to construct reliable interconnected models of Signaling, gene Regulatory, and metabolic pathways. Methods Mol. Biol. 2634, 139\u2013151 (2023).","journal-title":"Methods Mol. Biol."},{"key":"26955_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12859-019-2682-z","volume":"20","author":"N Sompairac","year":"2019","unstructured":"Sompairac, N. et al. Metabolic and signalling network maps integration: application to cross-talk studies and omics data analysis in cancer. BMC Bioinf. 20, 140 (2019).","journal-title":"BMC Bioinf."},{"key":"26955_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","volume":"23","author":"X Peng","year":"2018","unstructured":"Peng, X. et al. Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers. Cell. Rep. 23, 255\u2013269e4 (2018).","journal-title":"Cell. Rep."},{"key":"26955_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer. 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"26955_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"26955_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"26955_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You, M. et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Sig Transduct. Target. Ther. 8, 196 (2023).","journal-title":"Sig Transduct. Target. Ther."},{"key":"26955_CR18","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/onc.2014.321","volume":"34","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Metabolic reprogramming during TGF\u03b21-induced epithelial-to-mesenchymal transition. Oncogene 34, 3908\u20133916 (2015).","journal-title":"Oncogene"},{"key":"26955_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3892\/or.2021.7946","volume":"45","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review). Oncol. Rep. 45, 846\u2013856 (2021).","journal-title":"Oncol. Rep."},{"key":"26955_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/1878-0261.12639","volume":"14","author":"C Yang","year":"2020","unstructured":"Yang, C., Huang, X., Liu, Z., Qin, W. & Wang, C. Metabolism-associated molecular classification of hepatocellular carcinoma. Mol. Oncol. 14, 896\u2013913 (2020).","journal-title":"Mol. Oncol."},{"key":"26955_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the Serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"issue":"D1","key":"26955_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"26955_CR23","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"26955_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"26955_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816 (2022).","journal-title":"Nat. Commun."},{"key":"26955_CR26","doi-asserted-by":"publisher","first-page":"e004210","DOI":"10.1136\/jitc-2021-004210","volume":"10","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. J. ImmunoTher Cancer. 10, e004210 (2022).","journal-title":"J. ImmunoTher Cancer"},{"key":"26955_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-52134-4","volume":"9","author":"S Bhalla","year":"2019","unstructured":"Bhalla, S., Kaur, H., Dhall, A. & Raghava, G. P. S. Prediction and analysis of skin cancer progression using genomics profiles of patients. Sci. Rep. 9, 1\u201316 (2019).","journal-title":"Sci. Rep."},{"key":"26955_CR28","doi-asserted-by":"publisher","first-page":"101030","DOI":"10.1016\/j.cpsurg.2021.101030","volume":"59","author":"K Newcomer","year":"2022","unstructured":"Newcomer, K. et al. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies. Curr. Probl. Surg. 59, 101030 (2022).","journal-title":"Curr. Probl. Surg."},{"key":"26955_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan, A. et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature 577, 115\u2013120 (2020).","journal-title":"Nature"},{"key":"26955_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol. Cancer. 20, 28 (2021).","journal-title":"Mol. Cancer"},{"key":"26955_CR31","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.3390\/ijms24086945","volume":"24","author":"G Munk\u00e1csy","year":"2023","unstructured":"Munk\u00e1csy, G., Santarpia, L. & Gy\u0151rffy, B. Therapeutic potential of tumor metabolic reprogramming in Triple-Negative breast cancer. Int. J. Mol. Sci. 24, 6945 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"26955_CR32","doi-asserted-by":"publisher","first-page":"djw144","DOI":"10.1093\/jnci\/djw144","volume":"108","author":"MD Iglesia","year":"2016","unstructured":"Iglesia, M. D. et al. Genomic analysis of immune cell infiltrates across 11 tumor types. JNCI J. Natl. Cancer Inst. 108, djw144 (2016).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"26955_CR33","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/eji.200939722","volume":"39","author":"F Sallusto","year":"2009","unstructured":"Sallusto, F. & Lanzavecchia, A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39, 2076\u20132082 (2009).","journal-title":"Eur. J. Immunol."},{"key":"26955_CR34","doi-asserted-by":"publisher","first-page":"e170762","DOI":"10.1172\/JCI170762","volume":"133","author":"FG Ozbay Kurt","year":"2023","unstructured":"Ozbay Kurt, F. G., Lasser, S., Arkhypov, I., Utikal, J. & Umansky, V. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. J. Clin. Invest. 133, e170762 (2023).","journal-title":"J. Clin. Invest."},{"issue":"16","key":"26955_CR35","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson, N. M. & Simon, M. C. The tumor microenvironment. Curr. Biol. 30 (16), R921\u2013R925 (2020).","journal-title":"Curr. Biol."},{"key":"26955_CR36","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw, D. C. & Shevde, L. A. The tumor microenvironment innately modulates cancer progression. Cancer Res. 79, 4557\u20134566 (2019).","journal-title":"Cancer Res."},{"key":"26955_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni, D., Angell, H. K. & Galon, J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer. 20, 662\u2013680 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"26955_CR38","unstructured":"Emens, L. A. & Middleton, G. The interplay of immunotherapy and chemotherapy: Harnessing potential synergies. Cancer Immunol. Res.."},{"key":"26955_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s11658-022-00378-w","volume":"27","author":"Q Hu","year":"2022","unstructured":"Hu, Q. et al. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer. Cell. Mol. Biol. Lett. 27, 71 (2022).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"26955_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1042\/CS20190145","volume":"133","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR\/PI3K\/Akt\/mTOR axis. Clin. Sci. 133, 1167\u20131184 (2019).","journal-title":"Clin. Sci."},{"key":"26955_CR41","first-page":"1739","volume":"8","author":"W-T Hu","year":"2018","unstructured":"Hu, W-T., Yeh, C-C., Liu, S-Y., Huang, M-C. & Lai, I-R. The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities. Am. J. Cancer Res. 8, 1739\u20131751 (2018).","journal-title":"Am. J. Cancer Res."},{"key":"26955_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40364-023-00491-8","volume":"11","author":"J Yue","year":"2023","unstructured":"Yue, J., Huang, R., Lan, Z., Xiao, B. & Luo, Z. Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy. Biomark. Res. 11, 54 (2023).","journal-title":"Biomark. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26955-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T11:00:33Z","timestamp":1764759633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26955-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26955"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26955-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43045"}}